US 11525136
Modulators of APOL1 expression
granted A61KA61K31/7088A61P
Quick answer
US patent 11525136 (Modulators of APOL1 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/7088, A61P, A61P13/02